nejm semaglutide ckd Effects of with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial ❇️Patients with obesity, type 2

Suchankova et al., 2023)

Hematology focuses on blood-related conditions, including anemia, clotting disorders, and deficiencies that affect oxygen transport in the body

People with obesity already tend toward low vitamin D levels because the vitamin gets sequestered in adipose tissue

GLP-1 RAs also promote cardiovascular benefits (25), by mechanisms that have not yet been fully identified but that may involve, among others, actions on blood pressure and lipid profile (6)

Many private insurance plans already cover dietitian visits at no cost under Medical Nutrition Therapy benefits call your insurance and ask about code 97802

Triple-Hormone-Receptor Agonist Retatrutide for Obesity [correspondence]